Liver toxicity after treatment with gefitinib and anastrozole: drug-drug interactions through cytochrome p450?
Carlini
Paolo
P
Papaldo
Paola
P
Fabi
Alessandra
A
Felici
Alessandra
A
Ruggeri
Enzo Maria
EM
Milella
Michele
M
Ciccarese
Mariangela
M
Nuzzo
Carmen
C
Cognetti
Francesco
F
Ferretti
Gianluigi
G
D000077384:Anastrozole; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy / Q000473:pathology; D056486:Chemical and Drug Induced Liver Injury / Q000201:enzymology* / Q000209:etiology*; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism*; D004347:Drug Interactions; D005260:Female; D000077156:Gefitinib; D006801:Humans; D007527:Isoenzymes / Q000378:metabolism; D008207:Lymphatic Metastasis; D008875:Middle Aged; D009570:Nitriles / Q000008:administration & dosage / Q000009:adverse effects; D011799:Quinazolines / Q000008:administration & dosage / Q000009:adverse effects; D014230:Triazoles / Q000008:administration & dosage / Q000009:adverse effects
D007527:Isoenzymes; D009570:Nitriles; D011799:Quinazolines; D014230:Triazoles; D000077384:Anastrozole; D003577:Cytochrome P-450 Enzyme System; D000077156:Gefitinib